Sanofi was pleased to invite investors and analysts to attend its Vaccines Investor Event on Wednesday, December 1, 2021. This event provided an in-depth look at our Vaccines business: how we expect the vaccine market to evolve and our strategy to continue to be a strong growth driver through an innovative R&D pipeline.

Webcast Replay Vaccines: What's Next - Part 1

Webcast Replay Vaccines: What's Next - Part 2

"We’re building a highly innovative pipeline to address unmet needs by providing new vaccines solutions and unlocking the potential of mRNA"

Thomas Triomphe, Sanofi's EVP for Vaccines

Sanofi Pipeline

mRNA Technology: Vaccines and Beyond

Research & Development